Codex Biosolutions (United States)
- Research works
- 11 ▼ 48% vs 2018-21
- Citations
- 463 41.9 per fractional work
- Top-10% rate
- 17.2% all institutions 10.0%
- Open access
- 59% world 40%
- International
- 24% world 18%
Not ranked overall: Codex Biosolutions (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Codex Biosolutions (United States) work in?
In all years, 48% of research at Codex Biosolutions (United States) is in Health Sciences, 38% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (8%). It does 1.5× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 10 fields, with their numbers
- Health Sciences548.1%
- Medicine548.1%
- Life Sciences438.1%
- Physical Sciences17.2%
- Engineering03.3%
- Environmental Science02.4%
- Computer Science01.5%
- Social Sciences16.7%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.8×. Every wedge is a field page.
All 8 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology4.84×1 works
- Immunology and Microbiology3.60×0 works
- Medicine2.96×2 works
- Neuroscience1.79×0 works
- Psychology1.07×0 works
- Agricultural and Biological Sciences0.78×0 works
- Engineering0.20×0 works
- Environmental Science0.18×0 works
Which research topics does Codex Biosolutions (United States) publish most on?
By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, Tissue Engineering and Regenerative Medicine, CAR-T cell therapy research and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 2 Tissue Engineering and Regenerative Medicine Surgery 0 works
- 3 CAR-T cell therapy research Oncology 0 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 5 Protein purification and stability Molecular Biology 0 works
- 6 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 7 Congenital heart defects research Molecular Biology 0 works
- 8 Pluripotent Stem Cells Research Molecular Biology 0 works
- 9 Multiple Myeloma Research and Treatments Hematology 0 works
- 10 SARS-CoV-2 detection and testing Infectious Diseases 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Codex Biosolutions (United States)'s research output changed?
Output in 2022-2025 was 48% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Codex Biosolutions (United States) as a percentage of every work published that year, 0.0000020% in 2024.
Fractional works of Codex Biosolutions (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- Robotic Research (United States)
- GenVec
- CVPath Institute
- Identity
- Integrated BioTherapeutics (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Codex Biosolutions (United States). Posts are plain text and can be reported.